公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2013 | Neoadjuvant chemotherapy with docetaxel-cisplatin in patients with stage III N2 non-small-cell lung cancer | WEI-YU LIAO ; Chen J.-H.; Wu M.; JIN-YUAN SHIH ; KUAN-YU CHEN ; CHAO-CHI HO ; CHIH-HSIN YANG ; CHONG-JEN YU | Clinical Lung Cancer | 22 | 20 | |
2023 | Oral uracil–tegafur compared with intravenous chemotherapy as adjuvant therapy for resected early-stage non-small cell lung cancer patients | SHENG-KAI LIANG ; Wu, Chang-Wei; Chang, Ching-I; LI-TA KENG ; MENG-RUI LEE ; JANN-YUAN WANG ; JEN-CHUNG KO ; WEI-YU LIAO ; KUAN-YU CHEN ; CHAO-CHI HO ; JIN-YUAN SHIH ; CHONG-JEN YU | Cancer medicine | 0 | 0 | |
2018 | Outcomes in patients with non-small-cell lung cancer and acquired Thr790Met mutation treated with osimertinib: a genomic study | CHIA-CHI LIN ; JIN-YUAN SHIH ; CHONG-JEN YU ; CHAO-CHI HO ; WEI-YU LIAO ; JIH-HSIANG LEE ; TZU-HSIU TSAI ; KANG-YI SU ; MIN-SHU HSIEH ; YIH-LEONG CHANG ; Bai Y.-Y.; DE-RUI HUANG ; Thress K.S.; CHIH-HSIN YANG | The Lancet Respiratory Medicine | 120 | 109 | |
2002 | Pneumothorax in the ICU: Patient outcomes and prognostic factors | KUAN-YU CHEN ; JIH-SHUIN JERNG ; WEI-YU LIAO ; Ding L.-W.; LU-CHENG KUO ; JANN-YUAN WANG ; PAN-CHYR YANG | Chest | 62 | 60 | |
2017 | Predictive factors for EGFR-tyrosine kinase inhibitor retreatment in patients with EGFR-mutated non-small-cell lung cancer – A multicenter retrospective SEQUENCE study | Chang G.-C.; Tseng C.-H.; Hsu K.-H.; CHONG-JEN YU ; Yang C.-T.; Chen K.-C.; Yang T.-Y.; Tseng J.-S.; Liu C.-Y.; WEI-YU LIAO ; Hsia T.-C.; Tu C.-Y.; Lin M.-C.; Tsai Y.-H.; Hsieh M.-J.; Wu W.-S.; Chen Y.-M. | Lung Cancer | 22 | 18 | |
2014 | Prior EGFR tyrosine-kinase inhibitor therapy did not influence the efficacy of subsequent pemetrexed plus platinum in advanced chemonaïve patients with EGFR-mutant lung adenocarcinoma | Tseng, Jeng-Sen; Yang, Tsung-Ying; Chen, Kun-Chieh; Hsu, Kuo-Hsuan; CHONG-JEN YU ; WEI-YU LIAO ; Tsai, Chi-Ren; Tsai, Meen-Hsin; SUNG-LIANG YU ; KANG-YI SU ; Chen, Jeremy Jw; Chen, Hsuan-Yu; MONG-HSUN TSAI | OncoTargets and Therapy | 15 | 14 | |
2021 | Prognostic Characteristics and Immunotherapy Response of Patients With Nonsquamous NSCLC With Kras Mutation in East Asian Populations: A Single-Center Cohort Study in Taiwan | SHANG-GIN WU ; WEI-YU LIAO ; KANG-YI SU ; SUNG-LIANG YU ; YEN-LIN HUANG ; CHONG-JEN YU ; CHIH-HSIN YANG ; JIN-YUAN SHIH | JTO Clinical and Research Reports | 16 | 0 | |
2018 | Prognostic factors of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma: a real-world, large cohort study | SHENG-KAI LIANG ; MENG-RUI LEE ; WEI-YU LIAO ; CHAO-CHI HO ; JEN-CHUNG KO ; JIN-YUAN SHIH | Oncotarget | 17 | 0 | |
2016 | Prospective evaluation of procalcitonin, soluble triggering receptor expressed on myeloid cells-1 and c-reactive protein in febrile patients with autoimmune diseases | Lin C.-H.; SONG-CHOU HSIEH ; LI-TA KENG ; Lee H.-S.; Chang H.-T.; WEI-YU LIAO ; CHAO-CHI HO ; CHONG-JEN YU | PLoS ONE | 6 | 5 | |
2018 | Psychological distress and coping strategies among women with incurable lung cancer: a qualitative study | Liao Y.-C.; WEI-YU LIAO ; Sun J.-L.; JEN-CHANG KO ; CHONG-JEN YU | Supportive Care in Cancer | 22 | 18 | |
2014 | Quality of life and related factors in patients with newly diagnosed advanced lung cancer: A longitudinal study | Liao Y.-C.; Shun S.-C.; WEI-YU LIAO ; CHONG-JEN YU ; PAN-CHYR YANG ; YEUR-HUR LAI | Oncology Nursing Forum | 39 | 39 | |
2017 | Real-world data on prognostic factors for overall survival in EGFR mutation-positive advanced non-small cell lung cancer patients treated with first-line gefitinib | ZONG-HAN YAO ; WEI-YU LIAO ; CHAO-CHI HO ; KUAN-YU CHEN ; JIN-YUAN SHIH ; JIN-SHING CHEN ; ZHONG-ZHE LIN ; Chia-Chi Lin ; CHIH-HSIN YANG ; CHONG-JEN YU | Oncologist | 25 | 25 | |
2022 | Real-world treatment patterns and outcomes among patients with advanced non-small-cell lung cancer with spindle cell and/or giant cell carcinoma | CHIA-LING CHANG ; MIN-SHU HSIEH ; JIN-YUAN SHIH ; Lee, Yi-Hsuan; WEI-YU LIAO ; CHIA-LIN HSU ; CHING-YAO YANG ; KUAN-YU CHEN ; JIH-HSIANG LEE ; CHAO-CHI HO ; TZU-HSIU TSAI ; CHIH-HSIN YANG ; CHONG-JEN YU | Therapeutic advances in medical oncology | 1 | 1 | |
2021 | The relative importance of predictive factors for single first-generation EGFR-TKI use for more than 5 years in patients with advanced non-small cell lung cancer: Taiwan multicenter TIPS-5 study | Huang, Yen-Hsiang; Hung, Jen-Yu; Ko, How-Wen; Su, Po-Lan; Lai, Chun-Liang; Chang, Huang-Chih; Hsia, Te-Chun; Lin, Sheng-Hao; Wu, Kuan-Li; Yang, Cheng-Ta; Su, Wu-Chou; Chu, Yi-Chun; Wang, Chin-Chou; WEI-YU LIAO ; YEN-TING LIN ; Lin, Ching-Hsiung; Lin, Meng-Chih; Hsu, Kuo-Hsuan; Tseng, Jeng-Sen; Yang, Tsung-Ying; Chen, Kun-Chieh; Lee, Mei-Hsuan; SUNG-LIANG YU ; CHAO-CHI HO ; Chang, Gee-Chen | Therapeutic advances in medical oncology | 3 | 2 | |
2012 | Risk Factors of Pneumothorax after Endobronchial Ultrasound-Guided Transbronchial Biopsy for Peripheral Lung Lesions | CHUN-TA HUANG ; SHENG-YUAN RUAN ; WEI-YU LIAO ; YAO-WEN KUO ; Lin C.-Y.; Tsai Y.-J.; CHAO-CHI HO ; CHONG-JEN YU | PLoS ONE | 26 | 25 | |
2021 | Serial Plasma Cell-Free Circulating Tumor DNA Tests Identify Genomic Alterations for Early Prediction of Osimertinib Treatment Outcome in EGFR T790M–Positive NSCLC | BIN-CHI LIAO ; Hsu, Wei-Hsun; JIH-HSIANG LEE ; CHING-YAO YANG ; TZU-HSIU TSAI ; WEI-YU LIAO ; CHAO-CHI HO ; CHIA-CHI LIN ; JIN-YUAN SHIH ; CHONG-JEN YU ; Soo, Ross A; CHIH-HSIN YANG | JTO clinical and research reports | 2 | 0 | |
2013 | Survival of lung adenocarcinoma patients with malignant pleural effusion | SHANG-GIN WU ; CHONG-JEN YU ; Tsai M.-F.; WEI-YU LIAO ; CHIH-HSIN YANG ; I-SHIOW JAN ; PAN-CHYR YANG ; JIN-YUAN SHIH | European Respiratory Journal | 86 | 77 | |
2011 | Symptoms, psychological distress, and supportive care needs in lung cancer patients | Liao Y.-C.; WEI-YU LIAO ; Shun S.-C.; CHONG-JEN YU ; PAN-CHYR YANG ; YEUR-HUR LAI | Supportive Care in Cancer | 71 | 68 | |
2004 | Testing the functional status model in patients with chronic obstructive pulmonary disease | Yeh M.-L.; Chen H.-H.; Liao Y.-C.; WEI-YU LIAO | Journal of Advanced Nursing | 32 | 24 | |
2024 | Tissue or liquid rebiopsy? A prospective study for simultaneous tissue and liquid NGS after first-line EGFR inhibitor resistance in lung cancer | YEN-TING LIN ; CHAO-CHI HO ; Hsu, Wei-Hsun; WEI-YU LIAO ; CHING-YAO YANG ; CHONG-JEN YU ; TZU-HSIU TSAI ; CHIH-HSIN YANG ; SHANG-GIN WU ; CHIA-LIN HSU ; Hsieh, Min-Shu; YEN-LIN HUANG ; Wu, Chia-Ling; JIN-YUAN SHIH | Cancer medicine | 0 | | |